Either of the injectibles should be injected subcutaneously (just under the skin), typically in the abdomen, thigh, or upper arm
Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist currently in Phase 3 trials
at 69 months, her ponytail looks fuller
For the foundational background on bacteriostatic water, see What Is Bacteriostatic Water
Are there any known side effects of BPC-157 Rapid
An open-label placebo-controlled trial enrolled 77 people with elevated LDL cholesterol and triglycerides and randomized them into four groups: 1) placebo, 2) 10 mg or 20 mg daily of rosuvastatin, 3) bergamot polyphenols, and 4) bergamot polyphenols plus 10 mg rosuvastatin